Bone and muscle protective potential of the prostate-sparing synthetic androgen 7α-methyl-19-nortestosterone: Evidence from the aged orchidectomized male rat model
- 30 April 2005
- Vol. 36 (4) , 663-670
- https://doi.org/10.1016/j.bone.2005.01.003
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Osteoporosis during androgen deprivation therapy for prostate cancerUrology, 2002
- Sex Steroids and the Construction and Conservation of the Adult SkeletonEndocrine Reviews, 2002
- Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation TherapyJournal of Urology, 2002
- Pathogenesis of bone fragility in women and menThe Lancet, 2002
- Changes in Body Composition during Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Endocrinology & Metabolism, 2002
- Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy MenJournal of Clinical Endocrinology & Metabolism, 2001
- Selective Androgen Receptor Modulators (SARMs): A Novel Approach to Androgen Therapy for the New MillenniumJournal of Clinical Endocrinology & Metabolism, 1999
- A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging MenJournal of Bone and Mineral Research, 1998
- Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*Journal of Clinical Endocrinology & Metabolism, 1991
- Castrated Men Exhibit Bone Loss: Effect of Calcitonin Treatment on Biochemical Indices of Bone Remodeling*Journal of Clinical Endocrinology & Metabolism, 1989